Clinical comparison of borreliacidal-antibody test with indirect immunofluorescence and enzyme-linked immunosorbent assays for diagnosis of lyme disease

Mayo Clinic Proceedings

Volumn 72, Issue 6, 1997, Pages 510-514

  Agger, William A ^a,b,c   Case, Kay L ^a,b  

^a Section of Infectious Disease   (United States)

^b Department of Immunology and Microbiology ^*  (United States)

^c GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BORRELIA; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LYME DISEASE; MAJOR CLINICAL STUDY;

EID: 0030746509     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.6.510     Document Type: Article

References (27)

1. Magnarelli LA. Sérologie diagnosis of Lyme disease. Ann N Y AcadSci 1988; 539:154-161
2. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 1984; 149:465-470
3. Feder HM Jr, Gerber MA, Luger SW, Ryan RW. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis 1992; 15:788-793
4. Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol 1994; 32:1519-1525
5. Kaell AT, Redecha PR, Elkon KB, Golightly MG, Schulman PE, Dattwyler RJ, et al. Occurrence of antibodies to Borrelia burgdorferi in patients with nonspirochetal subacute bacterial endocarditis. Ann Intern Med 1993; 119:1079-1083
6. Callister SM, Schell RF, Lovrich SD. Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol 1991 ; 29:17731776
7. Sadziene A, Thompson PA, Barbour AG. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis 1993; 167:165-172
8. Callister SM, Schell RF, Case KL, Lovrich SD, Day SP. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a sérodiagnostic test. J Infect Dis 1993; 167:158-164
9. Callister SM, Schell RF, Lim LCL, Jobe DA, Case KL, Bryant GL, et al. Detection of borreliacidal antibodies by flow cytometry: an accurate, highly specific sérodiagnostic test for Lyme disease. Arch Intern Med 1994; 154:1625-1632
10. Agger WA. Isolating Borrelia burgdorferi from erythema migrans [letter]. Ann Intern Med 1993; 119:953-954
11. Agger W, Case KL, Bryant GL, Callister SM. Lyme disease: clinical features, classification, and epidemiology in the upper midwest. Medicine 1991; 70:83-90
12. Nocton JJ, Dressier F, Rutledge B J, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330:229-234
13. Mitchell PD, Reed KD, Aspeslet TL, Vandermause MF, Melski JW. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol 1994; 32:1958-1962
14. Corpuz M, Hilton E, Lardis MP, Singer C, Zolan J. Problems in the use of sérologie tests for the diagnosis of Lyme disease. Arch Intern Med 1991; 151:1837-1840
15. Fister RD, Weymouth LA, McLaughlin JC, Ryan RW, Tilton RC. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J Clin Microbiol 1989; 27:2834-2837
16. Hedberg CW, Osterholm MT, MacDonald KL, White KE. An interlaboratory study of antibody to Borrelia burgdorferi. J Infect Dis 1987; 155:1325-1327
17. Luger SW, Krauss E. Serologie tests for Lyme disease: interlaboratory variability. Arch Intern Med 1990; 150:761-763
18. Schwartz BS, Goldstein MD, Ribeiro JMC, Schulze TL, Shahied SI. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA 1989; 262:3431-3434
19. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392400
20. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995; 33:419-427
21. Centers for Disease Control and Prevention. Lyme disease surveillance summary. 1995; 6(No. 2): 1-4
22. Zoller L, Burkard S, Schafer H. Validity of Western immunoblot band patterns in the serodiagnosis of Lyme borreliosis. J Clin Microbiol 1991; 29:174-182
23. Gabritschewsky G. Les bases de la sérothérapie de la fièvre récurrente. Ann Inst Pasteur 1896; 10:630-659
24. Callister SM, Jobe DA, Schell RF, Pavia CS, Lovrich SD. Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a 'gold standard'? Clin Diagn Lab Immunol 1996; 3:399402
25. Lachs MS, Nachamkin I, Edelstein PH, Goldman J, Feinstein AR, Schwartz JS. Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med 1992; 117:135-140
26. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologie Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44:590-591
27. Hilton E, Devoti J, Sood S. Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease. J Clin Microbiol 1996; 34:1353-1354